Oceania Healthcare (ASX:OCA) 3-Year RORE % : 0.00% (As of Mar. 2026)


ASX:OCA Oceania Healthcare Ltd ASX:OCA
45 GF Score
Price A$0.62
GF Value A$0.71
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Oceania Healthcare 3-Year RORE %?

Oceania Healthcare ASX:OCA 45 3-Year RORE % is 0.00 as of Mar. 2026. GuruFocus rates ASX:OCA with a GF Score™ of 45/100 and a GF Value™ of A$0.71 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 605 Healthcare Providers & Services companies, Oceania Healthcare ranks worse than 165289.09% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Oceania Healthcare's 3-Year RORE % for the quarter that ended in Mar. 2026 was 0.00%.

The industry rank for Oceania Healthcare's 3-Year RORE % or its related term are showing as below:

ASX:OCA's 3-Year RORE % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: -0.32
* Ranked among companies with meaningful 3-Year RORE % only.

Oceania Healthcare  (ASX:OCA) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Oceania Healthcare 3-Year RORE % Related Terms


Oceania Healthcare 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Oceania Healthcare's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oceania Healthcare 3-Year RORE % Chart

Oceania Healthcare Annual Data
Trend May17 May18 May19 May20 Mar22 Mar23 Mar24 Mar25 Mar26
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 -64.18 32.14 0.00

Oceania Healthcare Semi-Annual Data
May17 Nov17 May18 Nov18 May19 Nov19 May20 Nov20 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -64.18 -663.64 32.14 23.08 0.00

ASX:OCA vs HCA, THC, DVA: 3-Year RORE % Comparison

For the Medical Care Facilities subindustry, Oceania Healthcare's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oceania Healthcare 3-Year RORE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Oceania Healthcare's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Oceania Healthcare's 3-Year RORE % falls into.


ASX:OCA
45GF Score
Oceania Healthcare Ltd ASX:OCA
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oceania Healthcare 3-Year RORE % Calculation

Oceania Healthcare's 3-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( - )/( 0.078-0.01 )
=/0.068
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of 0.00 mean?
Oceania Healthcare (ASX:OCA) has a 3-Year RORE % of 0.00 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Oceania Healthcare and its competitors. According to the industry distribution chart, Oceania Healthcare ranks #999999 out of 605 companies in the Healthcare Providers & Services industry.
Is Oceania Healthcare's 3-Year RORE % too high?
Oceania Healthcare's current 3-Year RORE % is 0.00. Based on the distribution chart, Oceania Healthcare ranks #999999 out of 605 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Oceania Healthcare has a GF Score™ of 45/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Oceania Healthcare's 3-Year RORE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Oceania Healthcare ranks #999999 out of 605 companies for 3-Year RORE %. This places Oceania Healthcare in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
A good 3-Year RORE % depends on the Healthcare Providers & Services industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Oceania Healthcare and its competitors. Oceania Healthcare's current 3-Year RORE % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oceania Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Oceania Healthcare (ASX:OCA) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.71, compared to a current price of A$0.62 — trading 13.4% below its estimated fair value. The current 3-Year RORE % is 0.00. Oceania Healthcare's overall GF Score™ is 45/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Oceania Healthcare (ASX:OCA), the current 3-Year RORE % is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Oceania Healthcare (ASX:OCA) Overvalued in 2026?

Based on GuruFocus' analysis, Oceania Healthcare stock appears to be undervalued. The current stock price of A$0.62 is trading 13.4% below its estimated GF Value™ of A$0.71. GuruFocus considers Oceania Healthcare to be Modestly Undervalued.

Key valuation signals for ASX:OCA:

  • 3-Year RORE %: 0.00
  • GF Value™: A$0.71 vs. price of A$0.62 (13.4% below fair value)
  • GF Score™: 45/100 with 4 warning signs

No single metric tells the full story. See the ASX:OCA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Oceania Healthcare Business Description

Other Exchanges OCA:New Zealand
Address 188 Quay Street, Level 26, HSBC Tower, Auckland, NTL, NZL, 1010
Oceania Healthcare Ltd owns and operates rest homes and retirement villages. The business activities of the group are operated through care operations, village operations, and other segments. The company generates maximum revenue from the care operations segment, which includes traditional care beds and care suites as well as the provision of accommodation, care, care packages, meals, and related services to aged care residents. Geographically, it operates throughout New Zealand. The company derives revenue from Rest homes, hospitals, dementia fees, and others.
45GF Score

Get the complete analysis for ASX:OCA

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.62
Price
A$0.71
GF Value